Paradigm4 company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series A - II | Alive

Total Raised


About Paradigm4

Paradigm4 is the developer of SciDB, a scalable, computational database management system designed for advanced analytics on multidimensional data. SciDB radically reduces the ask-to-answer loop-accelerating data-driven discovery.

Paradigm4 Headquarters Location

281 Winter Street Suite 360

Waltham, Massachusetts, 02451,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Paradigm4

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Paradigm4 in 1 CB Insights research brief, most recently on Jan 31, 2022.

Expert Collections containing Paradigm4

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Paradigm4 is included in 1 Expert Collection, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Paradigm4 News

Paradigm4 launches Precision Cell Atlas

Jul 5, 2022

Paradigm4 launches Precision Cell Atlas Search jobs Paradigm4 launches Precision Cell Atlas 29 June 2022: Paradigm4 has launched the Precision Cell AtlasTM as an integral component of its REVEALTM: SingleCell app. The Precision Cell Atlas enables scientists to create a custom cell atlas by selectively combining an unlimited number of samples from multiple datasets for specific research objectives and explicitly saving them for collaboration, reuse, and regulatory filings. REVEAL: SingleCell, together with the Precision Cell Atlas capability, includes industry standard statistical tools to assess the sample-to-sample variation in gene vectors while retaining the provenance from the original project metadata for each sample. Metadata is tracked in the immutable log files recorded with REVEAL: SingleCell. With its initial launch in 2020, REVEAL: SingleCell was developed to offer biopharmaceutical computational biologists the ability to break through the data wrangling and programming challenges associated with the analysis of large-scale, single-cell datasets. The app enables users to navigate multimodal disease biology, scale to handle more samples from patients with more cells, more features, and diverse data types. Users can readily assess key biological hypotheses for target evaluation, disease progression, and precision medicine applications. Paradigm4’s REVEAL suite of use case-specific applications were built to transform scalable translational understanding from whole body to organelle. Other apps developed by Paradigm4 include REVEALTM: Proteomics and REVEALTM: Biobank. The apps are powered by Paradigm4’s unique technology stack, designed for scalable and interactive exploration, analytics, and machine learning on heterogeneous and highly dimensional scientific data sets. Zachary Pitluk, Ph.D., VP of Life Sciences and Healthcare at Paradigm4, commented: “Since its launch, REVEAL: SingleCell has been embraced by the single cell analysis community, with as many as 80 million cells in play in some installations. Current customer installations are supporting thousands of queries per day with the present implementation. Importantly, the addition of the Precision Cell Atlas functionality should increase the supportable queries and drive projects forward at a much faster rate than is currently available.”  Paradigm4 will be attending the 2022 Human Cell Atlas General Meeting, in Vienna, Austria. The annual meeting is taking place during from 27th – 29th June and Paradigm4 experts will be joining industry colleagues to discuss updates and research on new initiatives as they look towards the release of a first draft of the atlas. Paradigm4 will be on hand to answer questions about the recent advancements in REVEAL: SingleCell. For more information about Paradigm4, visit . ENDS  About Paradigm4  Paradigm4 transforms scalable translational understanding from whole body to organelle with its REVEAL Integrative Analytics Platform. REVEAL’s novel scientific data store integrated with its optimal elastic computing engine for exploration, analytics, and machine-learning delivers the trifecta of ease-of-use, unmatched performance, and exceptional cloud economics. REVEAL streamlines interactive, collaborative, and reproducible science, propelling drug development and precision medicine at global pharma and biotechs. Media contact

Paradigm4 Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Paradigm4 Rank

  • Where is Paradigm4's headquarters?

    Paradigm4's headquarters is located at 281 Winter Street, Waltham.

  • What is Paradigm4's latest funding round?

    Paradigm4's latest funding round is Series A - II.

  • How much did Paradigm4 raise?

    Paradigm4 raised a total of $44.84M.

  • Who are the investors of Paradigm4?

    Investors of Paradigm4 include Golden Seeds, Kepha Partners, Sigma Partners, Meyer Ventures, Deutsche Bank and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.